Page last updated: 2024-10-23

bisbenzimidazole and Hemolysis

bisbenzimidazole has been researched along with Hemolysis in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thamban Chandrika, N1
Shrestha, SK1
Ranjan, N1
Sharma, A1
Arya, DP1
Garneau-Tsodikova, S1
van Vianen, PH1
van Engen, A1
Thaithong, S1
van der Keur, M1
Tanke, HJ1
van der Kaay, HJ1
Mons, B1
Janse, CJ1

Other Studies

2 other studies available for bisbenzimidazole and Hemolysis

ArticleYear
New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.
    ACS infectious diseases, 2018, 02-09, Volume: 4, Issue:2

    Topics: Antifungal Agents; Biofilms; Bisbenzimidazole; Candida albicans; Dose-Response Relationship, Drug; F

2018
Flow cytometric screening of blood samples for malaria parasites.
    Cytometry, 1993, Volume: 14, Issue:3

    Topics: Animals; Bisbenzimidazole; Cell Count; Cell Separation; DNA; Flow Cytometry; Formaldehyde; Hemolysis

1993